 |
Diabetes
The following effects of the BEMER Therapy in the treatment of Diabetes mellitus are significant:
- • Increase of the blood circulation down to microcirculation (Michaelis, H)
- • Enhancement of oxygen partial pressure and un-clotting of the erythrocyte clusters (Malkomes, Ch)
- • Improved metabolism of the red blood cells through the filling up of the ATP- and other energy rich phosphate storage depots (Spodaryk, K)
- • Lowered blood pressure, reduction in pulse frequency and vegetative relaxation (Michels-Wakili, S)
- • Stimulation of any surviving, insulin- producing cells
- • Improvement of the oxygen supply and sugar metabolism (leading to a more evenly regulated blood-sugar daily profile and possibly the need for less medication to lower the blood sugar)
Organ functions can be positively affected by improved blood circulation and oxygen supply. Pain due to oxygen insufficiency and pressure on the heart can also be alleviated. The vegetative regulating effects can help to control blood pressure, depending on the condition of the blood vessels.
Overall the effects listed demonstrate that the BEMER Therapy can be an effective, non-intrusive method that can contribute to a better compensation for unavoidable individual risk factors, support for individual treatment and as a supplement to the necessary traditional therapies.
- • use of coil mat two to three times daily in accordance with the basic plan (Levels 3 through to 6)
- • if insulin is not required, then the use of the intensive applicator with P4 on the pancreas once daily is recommended
Individual schedules and modifications, especially in the use of the intensive applicator, are sometimes necessary due to the complexity of diabetic diseases and the often multi-morbid occurrences.
Literature:
- 1. Kafka, W. A., Extrem langsam und breitbandig gepulste elektromagnetische Felder niedriger Energie für den therapeutischen Einsatz, EMPHYSPACE REPORT 02.02.99
- 2. Michaelis, H., Fachinformation BEMER 3000 – Therapie, ACADEMY for Bioenergetics, 5/99
- 3. Akademie für Bioenergetik, Fürstentum Liechtenstein, Ärztliche Anwenderstudie, 09/03
Source © AFB 27. February 2004
|
|
|
